- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Anthem Biosciences Limited — Updates, 05-02-2026: Press Release
05-02-2026 | 01:45 pm
05-02-2026 | 01:45 pm
Anthem Biosciences delivered robust 9MFY26 results: Revenue ₹1,513.4 Cr (+11.2% YoY), PAT ₹402.0 Cr (+9.1% YoY). However, Q3FY26 saw revenue decline to ₹423.2 Cr and PAT to ₹92.8 Cr, partly due to an exceptional item. CRDMO business continues as primary driver.
No comments yet. Be the first to comment!